This is a clinical trial for: Cancer patients whose cancer has spread to their skin

In the United States there are over 600,000 people who die of cancer each year. Most commonly, cancer patients die from the progression of the disease outside their primary cancer site. This study is looking for patients that have not been responsive to their standard care treatment and whose associated cancer has now spread to their skin in the form of lesions (skin tumors).

Researchers are testing whether an investigational drug injected into solid tumors can signal the immune system to attack and kill cancer cells. Like all cancer trials, all participants receive the study drug – no placebo will be used.

Check eligibility

Study details

Eligibility requirements

Participants must:

  • be 18 years or older
  • have metastatic cancer that has spread to the skin
  • be non-responsive to standard treatments
  • have solid tumors on or near the skin (the study drug is injectable)

Participants must not:

  • be currently receiving cancer treatment
  • be pregnant or breastfeeding
  • be currently participating in another clinical trial

If you would like to speak to someone regarding this trial, first check to see if you are eligible above. If it seems that you are eligible to take part, you will be contacted by phone, and you will be able to ask any additional questions you may have about this clinical trial.